RXRX (Recursion Pharmaceuticals Inc) climbed 10.09 at the last close: Is This Today’s Most Popular Stock?

A new trading day began on Friday, with Recursion Pharmaceuticals Inc (NASDAQ: RXRX) stock price up 10.09% from the previous day of trading, before settling in for the closing price of $12.33. RXRX’s price has ranged from $4.54 to $16.75 over the past 52 weeks.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 173.07%. Meanwhile, its annual earnings per share averaged -21.23%. With a float of $151.89 million, this company’s outstanding shares have now reached $183.21 million.

Recursion Pharmaceuticals Inc (RXRX) Breakdown of a Key Holders of the stock

As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Recursion Pharmaceuticals Inc is 29.65%, while institutional ownership is 71.22%. The most recent insider transaction that took place on Feb 07, was worth 444,981. In this transaction Chief Executive Officer of this company sold 48,272 shares at a rate of $9.22, taking the stock ownership to the 774,703 shares. Before that another transaction happened on Feb 06, when Company’s Director sold 11,447 for $9.30, making the entire transaction worth $106,489. This insider now owns 7,312,917 shares in total.

Recursion Pharmaceuticals Inc (RXRX) Recent Fiscal highlights

In its latest quarterly report, released on 9/30/2023, the company reported earnings of -$0.43 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -21.23% per share during the next fiscal year.

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Trading Performance Indicators

Here are Recursion Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.28. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 45.99.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.47, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -1.85 in one year’s time.

Technical Analysis of Recursion Pharmaceuticals Inc (RXRX)

Compared to the last year’s volume of 5.82 million, its volume of 3.18 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 50.48%. Additionally, its Average True Range was 0.79.

During the past 100 days, Recursion Pharmaceuticals Inc’s (RXRX) raw stochastic average was set at 55.59%, which indicates a significant decrease from 61.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.23% in the past 14 days, which was lower than the 85.05% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $9.68, while its 200-day Moving Average is $8.53. Nevertheless, the first resistance level for the watch stands at $10.24 in the near term. At $10.39, the stock is likely to face the second major resistance level. The third major resistance level sits at $10.59. If the price goes on to break the first support level at $9.88, it is likely to go to the next support level at $9.68. Now, if the price goes above the second support level, the third support stands at $9.53.

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Key Stats

With a market capitalization of 2.18 billion, the company has a total of 216,623K Shares Outstanding. Currently, annual sales are 39,840 K while annual income is -239,480 K. The company’s previous quarter sales were 10,530 K while its latest quarter income was -93,020 K.